Sponsor

BioVentrix

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name BioVentrix appears in 6 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials6
Recruiting shown0
Roles1
SourceClinicalTrials.gov
Advertisement

Clinical trials

6 shown
Randomized Evaluation and Verification of Ventricular EnhancementNCT03845127 · lead sponsor · 2020-01-01
WITHDRAWN
Clinical Study of the BioVentrix Revivent TC for the Treatment of Ischemic CardiomyopathyNCT02553785 · lead sponsor · 2015-06-01
COMPLETED
Safety and Efficacy Study of the BioVentrix PliCath HF SystemNCT01568164 · lead sponsor · 2012-03-01
COMPLETED
Prospective Study of the BioVentrix PliCath HF™ System for the Treatment of Ischemic CardiomyopathyNCT01568138 · lead sponsor · 2010-08-01
COMPLETED
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise CapacityNCT00326690 · lead sponsor · 2005-11-01
WITHDRAWN
ALIVE Expended Access - Clinical StudyNCT05710042 · lead sponsor
NO_LONGER_AVAILABLE

Sponsor roles

lead sponsor6

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.